Central Nervous System Stimulant
Methylphenidate for ADHD
Recruiting2 awardsPhase 4
Baltimore, Maryland
This trial studies how methylphenidate affects brain activity and chemicals in adults with ADHD using brain scans. The goal is to develop better treatments for ADHD. Methylphenidate is the most common treatment for attention deficit hyperactivity disorder (ADHD) and has been shown to improve attention and behaviour.
Popular Filters
Trials for Attention Deficit Hyperactivity Disorder (ADHD) Patients
Tolcapone for Alcoholism and ADHD
Recruiting0 awardsPhase 2
Aurora, Colorado
This trial tests tolcapone to see if it helps people with both alcohol use issues and attention problems. The study focuses on people with both AUD and ADHD. Tolcapone works by affecting brain chemicals related to mood and behavior. Initially used for Parkinson's disease, tolcapone might be considered for ADHD treatment.
Methylphenidate for ADHD
Recruiting3 awardsPhase 4
Gainesville, Florida
This trial is investigating how genetic differences in an enzyme called CES1 affect the way ADHD patients respond to the medication methylphenidate. The goal is to understand why some patients do not respond well or experience severe side effects. Methylphenidate (MPH) is a well-established treatment for ADHD, but not all patients respond to it, and some experience adverse reactions.
Behavioral Intervention
Exercise for ADHD in College Students
Recruiting1 award2 criteria
Laramie, Wyoming
This trialwill study if physical exercise can be an effective treatment for college students with ADHD with the potential to improve cognitive functioning while providing ancillary health benefits.
Behavioural Intervention
ADHD Interventions + Stimulant for ADHD
Recruiting5 awardsPhase 4
Miami, Florida
This trial tests different ways to help children with ADHD behave better in school. It starts with general classroom techniques, adds more focused help if needed, and uses advanced methods or medication if necessary. The study targets young children with ADHD who are not in special education or on medication. Medication has been extensively studied and shown to improve ADHD symptoms in children.
Trials for Attention Deficit Disorder Patients
Tolcapone for Alcoholism and ADHD
Recruiting0 awardsPhase 2
Aurora, Colorado
This trial tests tolcapone to see if it helps people with both alcohol use issues and attention problems. The study focuses on people with both AUD and ADHD. Tolcapone works by affecting brain chemicals related to mood and behavior. Initially used for Parkinson's disease, tolcapone might be considered for ADHD treatment.
Methylphenidate for ADHD
Recruiting3 awardsPhase 4
Gainesville, Florida
This trial is investigating how genetic differences in an enzyme called CES1 affect the way ADHD patients respond to the medication methylphenidate. The goal is to understand why some patients do not respond well or experience severe side effects. Methylphenidate (MPH) is a well-established treatment for ADHD, but not all patients respond to it, and some experience adverse reactions.
Behavioral Intervention
Exercise for ADHD in College Students
Recruiting1 award2 criteria
Laramie, Wyoming
This trialwill study if physical exercise can be an effective treatment for college students with ADHD with the potential to improve cognitive functioning while providing ancillary health benefits.
Behavioural Intervention
ADHD Interventions + Stimulant for ADHD
Recruiting5 awardsPhase 4
Miami, Florida
This trial tests different ways to help children with ADHD behave better in school. It starts with general classroom techniques, adds more focused help if needed, and uses advanced methods or medication if necessary. The study targets young children with ADHD who are not in special education or on medication. Medication has been extensively studied and shown to improve ADHD symptoms in children.
Phase 3 Trials
Stimulant
ADHD Medication + Parent Training for ADHD Families
Recruiting4 awardsPhase 3
College Park, Maryland
This trial will compare the effectiveness of treating ADHD in children when their parent also has ADHD, versus treating the child's ADHD alone. They will also study the parents' ADHD symptoms and how well they are able to engage in parent training.
Centanafadine for ADHD
Recruiting1 awardPhase 3
New York, New York
This trial will test if centanafadine, a daily extended-release medication, can help children aged 4 to 12 years with ADHD by balancing brain chemicals to improve focus and reduce hyperactivity. Centanafadine is being investigated for the treatment of ADHD.
Norepinephrine-Dopamine Reuptake Inhibitor
Centanafadine for ADHD
Recruiting2 awardsPhase 3
New York, New York
This trial aims to test the safety and tolerability of a daily ADHD medication in children and teens aged 4-17. The medication releases its effects slowly over the day to help manage symptoms consistently. HLD200 is a form of methylphenidate designed to provide benefits from morning until evening.
Behavioural Intervention
Solriamfetol for ADHD
Recruiting1 awardPhase 3
Orlando, Florida
This trial is testing solriamfetol, a medication that may help adults with ADHD by balancing brain chemicals that control focus and activity levels. Participants will take solriamfetol once daily for several weeks to see if it improves their symptoms. Solriamfetol has been studied for its effectiveness in treating excessive sleepiness related to narcolepsy and obstructive sleep apnea, showing improvements in sleep latency and overall sleepiness scores.
Trials With No Placebo
Methylphenidate for ADHD
Recruiting3 awardsPhase 4
Gainesville, Florida
This trial is investigating how genetic differences in an enzyme called CES1 affect the way ADHD patients respond to the medication methylphenidate. The goal is to understand why some patients do not respond well or experience severe side effects. Methylphenidate (MPH) is a well-established treatment for ADHD, but not all patients respond to it, and some experience adverse reactions.
Behavioral Intervention
Exercise for ADHD in College Students
Recruiting1 award2 criteria
Laramie, Wyoming
This trialwill study if physical exercise can be an effective treatment for college students with ADHD with the potential to improve cognitive functioning while providing ancillary health benefits.
Behavioural Intervention
ADHD Interventions + Stimulant for ADHD
Recruiting5 awardsPhase 4
Miami, Florida
This trial tests different ways to help children with ADHD behave better in school. It starts with general classroom techniques, adds more focused help if needed, and uses advanced methods or medication if necessary. The study targets young children with ADHD who are not in special education or on medication. Medication has been extensively studied and shown to improve ADHD symptoms in children.
Behavioral Intervention
Motor Attention Training for ADHD
Recruiting1 award2 criteria
Madison, Wisconsin
This trial is testing whether tai chi or exercise classes can help college students with ADHD. These activities are thought to improve focus and reduce inattention by enhancing brain function and lowering stress. Tai Chi is an increasingly popular practice that integrates movement with cognitive skills relevant to ADHD. The study will compare these interventions to see which is most effective.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.